Compound ID | 1222
Synonym(s): AIC 499 | AIC-499
Class: Beta-lactam
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor |
| Target Pathogen: | Active against hospital-acquired infections caused by Gram-negative bacteria including multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter |
| Description: | A monobactam |
| Institute where first reported: | AiCuris |
| Highest development stage: | Phase 1 |
| Development status: | Inactive |
| Reason dropped: | Undisclosed reasons |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/156587350 |
| Citations: |
|
| Patent: | https://patentscope.wipo.int/search/en/WO2013110643 |